A reason to smile:
an innovative approach
in the fight against cancer

BetaGlue Technologies can deliver a localized amount of energy via a simple, intra-operative, internal radiotherapy platform engineered to achieve maximum efficacy and much improved safety for the patients.

CONTACT US


Company & Team

A global team of industry professionals with a track record in bringing innovation to market is developing a new technology in the loco-regional therapy of solid tumors, cleared as a medical device worldwide.

DISCOVER MORE


BetaGlue Technologies in a Nutshell:
Localized Internal β-emitting
Radiotherapy

A new anti-tumoral compound based on 90Y β-emitting microspheres, embedded in a bio-compatible matrix and delivered to target with a proprietary delivery system.

The amount of energy needed is administered locally with a simple, intra-operative method for maximum efficacy and improved safety.

DISCOVER MORE


ADMINISTRATION OF RADIONUCLIDES

Our technology is the first one to allow a highly controlled administration of radionuclides directly into the tumoral mass (or on the surgical bed following its resection).

It achieves the highest efficacy where it is needed, while at the same time minimizing the risk of unwanted side effects, both locally and in the entire patient’s body.



PROPRIETARY ADMINISTRATION DEVICE

Administration device engineered to guarantee a precise delivery of the required dose of energy where it is needed, thus overcoming some disadvantages of external beam radiation therapy (EBRT).



MULTIPLE APPLICATIONS

The applications of this β-emitting radiotherapy platform vary from the intra-tumoral treatment of unresectable or metastatic tumors, to the treatment of surgical margins after tumor excision to avoid local recurrences.

Additional applications are in the prevention of complications following lung/liver biopsies, or other loco-regional treatments.



Contact us




BetaGlue
Technologies SpA


Lungadige Galtarossa 21
I-37133 Verona, Italy

Legal headquarters:

via San Primo 4
I-20121 Milano, Italy


info(at)betaglue.com

VAT number: 06496571214

REA MI-2502397

Paid-in capital: € 52.228


© BetaGlue 2019. All rights reserved.